Results 101 to 110 of about 20,745 (266)

The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol effluxs⃞

open access: yesJournal of Lipid Research, 2006
Serum paraoxonase (PON1) is a HDL-associated enzyme exhibiting potentially antiatherogenic properties. Here, we examined the common PON1-192R/Q human polymorphism. Despite numerous studies, the effect of this polymorphism on the antiatherogenic potential
Leonid Gaidukov   +3 more
doaj   +1 more source

Energy efficiency analysis of next-generation passive optical network (NG-PON) technologies in a major city network [PDF]

open access: yes, 2013
Ever-increasing bandwidth demands associated with mobile backhaul, content-rich services and the convergence of residential and business access will drive the need for next-generation passive optical networks (NG-PONs) in the long term. At the same time,
Colle, Didier   +5 more
core   +1 more source

Plasma proteome correlates of lipid and lipoprotein: biomarkers of metabolic diversity and inflammation in children of rural Nepal. [PDF]

open access: yes, 2019
Proteins involved in lipoprotein metabolism can modulate cardiovascular health. While often measured to assess adult metabolic diseases, little is known about the proteomes of lipoproteins and their relation to metabolic dysregulation and underlying ...
Christian, Parul   +9 more
core  

Association between Paraoxonase-1 p.Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population

open access: yesVascular Health and Risk Management, 2021
David Corredor-Orlandelli,1,* Santiago Sambracos-Parrado,1,* Santiago Mantilla-García,1 Josué Tovar-Tirado,1 Valentina Vega-Ramírez,1 Santiago David Mendoza-Ayús,1 Laura Catalina Peña,1 María Fernanda Leal,1 ...
Corredor-Orlandelli D   +14 more
doaj  

Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin*

open access: yesJournal of Lipid Research, 2008
Low-dose aspirin therapy has become a standard in the treatment of cardiovascular diseases. Aspirin has been shown to inhibit atherosclerosis in mouse models.
Priscilla Jaichander   +3 more
doaj   +1 more source

Effects of cumin extract on oxLDL, paraoxanase 1 activity, FBS, total cholesterol, triglycerides, HDL-C, LDL-C, Apo A1, and Apo B in in the patients with hypercholesterolemia. [PDF]

open access: yes, 2014
OBJECTIVES Paraoxanase 1 (PON1) plays a protective role against the oxidative modification of plasma lipoproteins and hydrolyzes lipid peroxides in human atherosclerotic lesions.
Farrokhi, E., Ghatreh Samani, K.
core   +3 more sources

Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population

open access: yesPLoS ONE, 2015
The purpose of the present study was to investigate the distribution of PON1 Q192R and L55M polymorphisms and activities in a North African population and to determine their association with cardiovascular complications. The prevalence of the QQ, QR, RR,
Abdelghani Bounafaa   +11 more
semanticscholar   +1 more source

Frontocingulate Dysfunction Is Associated with Depression and Decreased Serum PON1 in Methamphetamine-Dependent Patients

open access: yesNeuropsychiatric Disease and Treatment, 2020
Nooshin Ghavidel,1 Fariba Khodagholi,1 Abolhassan Ahmadiani,1 Reza Khosrowabadi,2 Sareh Asadi,3 Jamal Shams4 1Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2Institute for Cognitive and Brain Sciences, Shahid ...
Ghavidel N   +5 more
doaj  

Rare coding variation in paraoxonase-1 is associated with ischemic stroke in the NHLBI Exome Sequencing Project[S]

open access: yesJournal of Lipid Research, 2014
HDL-associated paraoxonase-1 (PON1) is an enzyme whose activity is associated with cerebrovascular disease. Common PON1 genetic variants have not been consistently associated with cerebrovascular disease.
Daniel Seung Kim   +16 more
doaj   +1 more source

Plasminogen activator inhibitor-1 level correlates with lipoprotein subfractions in obese non-diabetic subjects [PDF]

open access: yes, 2018
K
Fülöp, Péter   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy